2013
DOI: 10.1016/j.ijcard.2013.03.062
|View full text |Cite
|
Sign up to set email alerts
|

Mid-term prognostic value of coronary artery disease in patients undergoing transcatheter aortic valve implantation: A meta-analysis of adjusted observational results

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
51
0
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 114 publications
(59 citation statements)
references
References 28 publications
7
51
0
1
Order By: Relevance
“…A lower rate of comorbidities in female patients was confirmed in the present meta-analysis, as demonstrated by their higher ejection fraction and reduced incidence of stroke and coronary artery disease, although the latter has still an undetermined effect on prognosis after TAVI [40]. The higher incidence of coronary artery disease, leading to reduced areas of viable myocardium, is one reason for the less complete recovery of ejection fraction after TAVI in men, as recently demonstrated [17] with a clear negative effect on outcome.…”
Section: Commentsupporting
confidence: 73%
“…A lower rate of comorbidities in female patients was confirmed in the present meta-analysis, as demonstrated by their higher ejection fraction and reduced incidence of stroke and coronary artery disease, although the latter has still an undetermined effect on prognosis after TAVI [40]. The higher incidence of coronary artery disease, leading to reduced areas of viable myocardium, is one reason for the less complete recovery of ejection fraction after TAVI in men, as recently demonstrated [17] with a clear negative effect on outcome.…”
Section: Commentsupporting
confidence: 73%
“…1 Indeed, unlike CABG at the time of surgical aortic valve repair, 22,23 there is no agreement about the real benefit of treating coronary stenosis before or after TAVI in the absence of clear signs of ischemia. 24 In a group of 730 consecutive patients who underwent transapical TAVI, a single-stage combined treatment of severe AVS and CAD with PCI has been shown safe and feasible. Early and 3-year survival was comparable with that observed in patients without CAD who received TAVI only.…”
Section: Discussionmentioning
confidence: 99%
“…The robust clinical data showing that CAD per se is not an independent predictor of post-TAVR mortality 3,25 are probably explained by 2 factors:…”
Section: Discussionmentioning
confidence: 99%